Suppr超能文献

相似文献

1
Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.
Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):157-63. doi: 10.1016/j.plefa.2008.09.012. Epub 2008 Nov 12.
2
Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
J Intern Med. 2010 Jul;268(1):15-24. doi: 10.1111/j.1365-2796.2010.02235.x. Epub 2010 Apr 28.
3
Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators.
J Thromb Haemost. 2009 Jul;7 Suppl 1:44-8. doi: 10.1111/j.1538-7836.2009.03396.x.
5
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S200-15. doi: 10.1038/sj.bjp.0707489. Epub 2007 Oct 29.
6
Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.
Biochim Biophys Acta. 2015 Apr;1851(4):397-413. doi: 10.1016/j.bbalip.2014.08.006. Epub 2014 Aug 17.
7
Pro-resolving lipid mediators are leads for resolution physiology.
Nature. 2014 Jun 5;510(7503):92-101. doi: 10.1038/nature13479.
8
Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
Pharmacol Ther. 2005 Jan;105(1):7-21. doi: 10.1016/j.pharmthera.2004.09.002.
10
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
Annu Rev Immunol. 2007;25:101-37. doi: 10.1146/annurev.immunol.25.022106.141647.

引用本文的文献

2
Current experimental methods to investigate the impact of specialized pro-resolving lipid mediators on Sjögren's syndrome.
Front Immunol. 2023 Jan 12;13:1094278. doi: 10.3389/fimmu.2022.1094278. eCollection 2022.
3
Targeted and untargeted metabolomic approach for GDM diagnosis.
Front Mol Biosci. 2023 Jan 5;9:997436. doi: 10.3389/fmolb.2022.997436. eCollection 2022.
4
Something Smells Fishy: How Lipid Mediators Impact the Maternal-Fetal Interface and Neonatal Development.
Biomedicines. 2023 Jan 10;11(1):171. doi: 10.3390/biomedicines11010171.
5
Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.
Ann Diagn Pathol. 2022 Feb;56:151865. doi: 10.1016/j.anndiagpath.2021.151865. Epub 2021 Nov 17.
6
7
Resolvin E1 Reduces Leukotriene B4-Induced Intracellular Calcium Increase and Mucin Secretion in Rat Conjunctival Goblet Cells.
Am J Pathol. 2020 Sep;190(9):1823-1832. doi: 10.1016/j.ajpath.2020.06.001. Epub 2020 Jun 16.
8
Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
Clin Exp Dent Res. 2020 Apr;6(2):225-235. doi: 10.1002/cre2.260. Epub 2019 Dec 19.
9
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs.
J Exp Pharmacol. 2020 Feb 10;12:47-60. doi: 10.2147/JEP.S236792. eCollection 2020.

本文引用的文献

1
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
Nat Rev Immunol. 2008 May;8(5):349-61. doi: 10.1038/nri2294.
2
Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties.
Bioorg Med Chem Lett. 2008 Feb 15;18(4):1382-7. doi: 10.1016/j.bmcl.2008.01.013. Epub 2008 Jan 9.
3
Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo.
J Immunol. 2007 Nov 15;179(10):7021-9. doi: 10.4049/jimmunol.179.10.7021.
4
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S200-15. doi: 10.1038/sj.bjp.0707489. Epub 2007 Oct 29.
5
Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
J Med Chem. 2007 Nov 29;50(24):5894-902. doi: 10.1021/jm060270d. Epub 2007 Oct 26.
6
Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism.
FASEB J. 2007 Dec;21(14):3877-84. doi: 10.1096/fj.07-8653com. Epub 2007 Jul 11.
7
Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.
Nat Med. 2007 Jul;13(7):868-873. doi: 10.1038/nm1591. Epub 2007 Jun 24.
8
Resolvin E1 and protectin D1 activate inflammation-resolution programmes.
Nature. 2007 Jun 14;447(7146):869-74. doi: 10.1038/nature05877.
9
Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution.
FASEB J. 2007 Oct;21(12):3162-70. doi: 10.1096/fj.07-8473com. Epub 2007 May 11.
10
Signal transduction involved in protective effects of 15(R/S)-methyl- lipoxin A(4) on mesangioproliferative nephritis in rats.
Prostaglandins Leukot Essent Fatty Acids. 2007 Mar;76(3):173-80. doi: 10.1016/j.plefa.2006.12.006. Epub 2007 Feb 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验